FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10311411000001108: Valupak Senna 7.5mg tablets (BR Pharmaceuticals) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35533501000001114 Valupak Senna 7.5mg tablets (BR Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
41879301000001118 Valupak Senna 7.5mg tablets (BR Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sennoside B true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has specific active ingredient Senna fruit true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Is a Product containing precisely senna 7.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has active ingredient Senna false Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has active ingredient Sennoside false Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sennoside B false Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has specific active ingredient Total sennosides false Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has specific active ingredient Sennoside false Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sennoside B false Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Has basis of strength substance Sennoside B true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) 20 tablet Is pack of False Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Inferred relationship Existential restriction modifier
Valupak Senna 7.5mg tablets (BR Pharmaceuticals) 20 tablet Has AMP True Valupak Senna 7.5mg tablets (BR Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start